US Nuclear's Medical Isotope Production to Revolutionize Healthcare. NewMediaWire . Tue, Jan 30, 2024, 8:30 AM 3 min read. In This Article: UCLE .

US Nuclear Corp. LOS ANGELES, CA, Jan. 30, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire –One of the most critical problems faced by the healthcare industry worldwide is the severe shortage of ...

There are three natural isotopes of uranium — uranium-234 (U-234), uranium-235 (U-235) and uranium-238 (U-238). U-238 is the most common one, accounting for around 99 per cent of natural uranium found ...

International Isotopes Inc. manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, sodium iodide I-131 drug product, and radiochemicals for clinical ...

ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes. It operates in two segments, Nuclear Fuels and ...

I'm proud to be partnering with Oklo to help expand our domestic supplies of isotopes and tritium," said Atomic Alchemy founder and CEO Thomas Eiden. The company is working to solve shortages of ...

The Canadian Nuclear Isotope Council and nuclear innovation company Nuclear Promise X will explore the feasibility of using Canadian nuclear reactors to produce plutonium-238 for use in deep space ...

Nuclear fission is the process where a nucleus of a heavy atom, such as uranium or plutonium, breaks up into smaller, lighter nuclei. This can either be spontaneous or induced, but usually results ...

--ASP Isotopes Inc. NASDAQ: ASPI, an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today ...

A shortage of nuclear isotopes could mean cancer diagnosis delays. Lives will be lost because of a shortage of specialist medicine used to detect diseases such as breast and bowel cancer.

Eli Lilly, the world’s biggest pharmaceutical group by market value, is entering the business of nuclear isotope production, as cancer drugmakers seek to secure supply of radioactive materials ...